{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:11:09Z","timestamp":1780542669333,"version":"3.54.1"},"reference-count":77,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100004869","name":"Westf\u00e4lische Wilhelms-Universit\u00e4t M\u00fcnster","doi-asserted-by":"publisher","award":["Lud2\/008\/17"],"award-info":[{"award-number":["Lud2\/008\/17"]}],"id":[{"id":"10.13039\/501100004869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004869","name":"Westf\u00e4lische Wilhelms-Universit\u00e4t M\u00fcnster","doi-asserted-by":"publisher","award":["EhC2\/006\/15"],"award-info":[{"award-number":["EhC2\/006\/15"]}],"id":[{"id":"10.13039\/501100004869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1009\/B02"],"award-info":[{"award-number":["SFB1009\/B02"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Lu477\/23-1"],"award-info":[{"award-number":["Lu477\/23-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2017.02426","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T04:29:08Z","timestamp":1513225748000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Vemurafenib Limits Influenza A Virus Propagation by Targeting Multiple Signaling Pathways"],"prefix":"10.3389","volume":"8","author":[{"given":"Magdalena","family":"Holzberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Boergeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Schr\u00e4der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Ehrhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,12,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.3390\/v4113179","article-title":"Insight into alternative approaches for control of avian influenza in poultry, with emphasis on highly pathogenic H5N1","volume":"4","author":"Abdelwhab","year":"2012","journal-title":"Viruses"},{"key":"B2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijantimicag.2012.04.005","article-title":"Antiviral therapy: old and current issues","volume":"40","author":"Antonelli","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B3","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nature09454","article-title":"Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma","volume":"467","author":"Bollag","year":"2010","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrd3847","article-title":"Vemurafenib: the first drug approved for BRAF-mutant cancer","volume":"11","author":"Bollag","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"B5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1074\/jbc.M113.469239","article-title":"Inhibition of p38 mitogen-activated protein kinase impairs influenza virus-induced primary and secondary host gene responses and protects mice from lethal H5N1 infection","volume":"289","author":"B\u00f6rgeling","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.cellsig.2015.07.015","article-title":"MEK1 dependent and independent ERK activation regulates IL-10 and IL-12 production in bone marrow derived macrophages","volume":"27","author":"Bouhamdan","year":"2015","journal-title":"Cell. Signal."},{"key":"B7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.virol.2005.08.041","article-title":"Characterization of a mitochondrial-targeting signal in the PB2 protein of influenza viruses","volume":"344","author":"Carr","year":"2006","journal-title":"Virology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/370071a0","article-title":"PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase","volume":"370","author":"Chung","year":"1994","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.antiviral.2011.08.002","article-title":"Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo","volume":"92","author":"Droebner","year":"2011","journal-title":"Antiviral Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.1462-5822.2009.01309.x","article-title":"A new player in a deadly game: influenza viruses and the PI3K\/Akt signalling pathway","volume":"11","author":"Ehrhardt","year":"2009","journal-title":"Cell. Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1111\/j.1462-5822.2006.00713.x","article-title":"Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence","volume":"8","author":"Ehrhardt","year":"2006","journal-title":"Cell. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1921","DOI":"10.1038\/cddis.2015.261","article-title":"Inhibition of Notch1 signaling overcomes resistance to the death ligand Trail by specificity protein 1-dependent upregulation of death receptor 5","volume":"6","author":"Fassl","year":"2015","journal-title":"Cell Death Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fphys.2012.00355","article-title":"Crosstalk and signaling switches in mitogen-activated protein kinase cascades","volume":"3","author":"Fey","year":"2012","journal-title":"Front. Physiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"Flaherty","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"18590","DOI":"10.1073\/pnas.0507415102","article-title":"The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host","volume":"102","author":"Gabriel","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nrclinonc.2013.83","article-title":"Paradoxical oncogenesis\u2013the long-term effects of BRAF inhibition in melanoma","volume":"10","author":"Gibney","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1101\/gad.12.4.502","article-title":"4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway","volume":"12","author":"Gingras","year":"1998","journal-title":"Genes Dev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.antiviral.2017.03.024","article-title":"The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo","volume":"142","author":"Haasbach","year":"2017","journal-title":"Antiviral Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1755-148X.2010.00685.x","article-title":"PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells","volume":"23","author":"Halaban","year":"2010","journal-title":"Pigment Cell Melanoma Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1038\/sj.onc.1209965","article-title":"Mechanism of ASC-mediated apoptosis: bid-dependent apoptosis in type II cells","volume":"26","author":"Hasegawa","year":"2007","journal-title":"Oncogene"},{"key":"B23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature08833","article-title":"RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth","volume":"464","author":"Hatzivassiliou","year":"2010","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"12832","DOI":"10.1128\/JVI.01216-10","article-title":"Influenza A virus replication induces cell cycle arrest in G0\/G1 phase","volume":"84","author":"He","year":"2010","journal-title":"J. Virol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.cell.2009.12.040","article-title":"Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF","volume":"140","author":"Heidorn","year":"2010","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1189\/jlb.1011530","article-title":"Apoptosis signaling in influenza virus propagation, innate host defense, and lung injury","volume":"92","author":"Herold","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1074\/jbc.M309476200","article-title":"Bile acids up-regulate death receptor 5\/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1","volume":"279","author":"Higuchi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1111\/j.1462-5822.2011.01680.x","article-title":"Phosphatidylinositol-3-kinase (PI3K) is activated by influenza virus vRNA via the pathogen pattern receptor Rig-I to promote efficient type I interferon production","volume":"13","author":"Hrincius","year":"2011","journal-title":"Cell. Microbiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1462-5822.2010.01436.x","article-title":"CRK adaptor protein expression is required for efficient replication of avian influenza A viruses and controls JNK-mediated apoptotic responses","volume":"12","author":"Hrincius","year":"2010","journal-title":"Cell. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.cellsig.2016.05.009","article-title":"MEK2 controls the activation of MKK3\/MKK6-p38 axis involved in the MDA-MB-231 breast cancer cell survival: Correlation with cyclin D1 expression","volume":"28","author":"Huth","year":"2016","journal-title":"Cell. Signal."},{"key":"B31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrc776","article-title":"Death and anti-death: tumour resistance to apoptosis","volume":"2","author":"Igney","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"14903","DOI":"10.1073\/pnas.1008990107","article-title":"The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner","volume":"107","author":"Joseph","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B33","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/onc.2010.408","article-title":"Hyperactivation of MEK-ERK1\/2 signaling and resistance to apoptosis induced by the oncogenic B-RAF inhibitor, PLX4720, in mutant N-RAS melanoma cells","volume":"30","author":"Kaplan","year":"2011","journal-title":"Oncogene"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.1158\/1078-0432.CCR-14-0776","article-title":"FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutation","volume":"20","author":"Kim","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"10147","DOI":"10.1128\/JVI.79.16.10147-10154.2005","article-title":"p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1","volume":"79","author":"Lee","year":"2005","journal-title":"J. Virol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/08830180305216","article-title":"Influenza virus induction of apoptosis by intrinsic and extrinsic mechanisms","volume":"22","author":"Lowy","year":"2003","journal-title":"Int. Rev. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkp161","article-title":"Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy","volume":"64","author":"Ludwig","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1515\/BC.2011.121","article-title":"Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections","volume":"392","author":"Ludwig","year":"2011","journal-title":"Biol. Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"10990","DOI":"10.1074\/jbc.M009902200","article-title":"Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway","volume":"276","author":"Ludwig","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S1471-4914(02)00010-2","article-title":"Influenza-virus-induced signaling cascades: targets for antiviral therapy?","volume":"9","author":"Ludwig","year":"2003","journal-title":"Trends Mol. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1462-5822.2005.00678.x","article-title":"Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells","volume":"8","author":"Ludwig","year":"2006","journal-title":"Cell. Microbiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"11166","DOI":"10.1128\/JVI.76.21.11166-11171.2002","article-title":"The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors","volume":"76","author":"Ludwig","year":"2002","journal-title":"J. Virol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0014-5793(04)00108-5","article-title":"MEK inhibition impairs influenza B virus propagation without emergence of resistant variants","volume":"561","author":"Ludwig","year":"2004","journal-title":"FEBS Lett."},{"key":"B45","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1096\/fj.10-158766","article-title":"MAP kinase-activated protein kinases 2 and 3 are required for influenza A virus propagation and act via inhibition of PKR","volume":"24","author":"Luig","year":"2010","journal-title":"FASEB J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2174\/138945009789577972","article-title":"Antiviral agents for influenza: molecular targets, concerns of resistance, and new treatment options","volume":"10","author":"Maltezou","year":"2009","journal-title":"Curr. Drug Targets"},{"key":"B47","doi-asserted-by":"publisher","first-page":"11359","DOI":"10.1128\/JVI.00804-10","article-title":"Toll-like receptor 4-mediated activation of p38 mitogen-activated protein kinase is a determinant of respiratory virus entry and tropism","volume":"84","author":"Marchant","year":"2010","journal-title":"J. Virol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"16707","DOI":"10.1074\/jbc.M510233200","article-title":"Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Calpha-mediated activation of ERK signaling","volume":"281","author":"Marjuki","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/S0006-291X(03)01283-X","article-title":"ASK1 regulates influenza virus infection-induced apoptotic cell death","volume":"307","author":"Maruoka","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.4161\/cc.8.8.8147","article-title":"How ERK1\/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?","volume":"8","author":"Mebratu","year":"2009","journal-title":"Cell Cycle"},{"key":"B51","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.1128\/JVI.03531-14","article-title":"Influenza virus-induced caspase-dependent enlargement of nuclear pores promotes nuclear export of viral ribonucleoprotein complexes","volume":"89","author":"M\u00fchlbauer","year":"2015","journal-title":"J. Virol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1515\/hsz-2011-0270","article-title":"Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses","volume":"393","author":"Nacken","year":"2012","journal-title":"Biol. Chem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"16004","DOI":"10.1074\/jbc.M900146200","article-title":"Bcl-2 expression and p38MAPK activity in cells infected with influenza A virus: impact on virally induced apoptosis and viral replication","volume":"284","author":"Nencioni","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B54","doi-asserted-by":"publisher","first-page":"6639","DOI":"10.1038\/sj.onc.1207883","article-title":"Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice","volume":"23","author":"Olschl\u00e4ger","year":"2004","journal-title":"Oncogene"},{"key":"B55","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1126\/science.1132998","article-title":"RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates","volume":"314","author":"Pichlmair","year":"2006","journal-title":"Science"},{"key":"B56","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.antiviral.2013.04.008","article-title":"Development of cellular signaling pathway inhibitors as new antivirals against influenza","volume":"98","author":"Planz","year":"2013","journal-title":"Antiviral Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.1128\/JVI.75.10.4871-4877.2001","article-title":"MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells","volume":"75","author":"Planz","year":"2001","journal-title":"J. Virol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/35060098","article-title":"Influenza virus propagation is impaired by inhibition of the Raf\/MEK\/ERK signalling cascade","volume":"3","author":"Pleschka","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature08902","article-title":"RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF","volume":"464","author":"Poulikakos","year":"2010","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"B62","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/infdis\/jir716","article-title":"Synergistic adaptive mutations in the hemagglutinin and polymerase acidic protein lead to increased virulence of pandemic 2009 H1N1 influenza A virus in mice","volume":"205","author":"Seyer","year":"2012","journal-title":"J. Infect. Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1099\/vir.0.82483-0","article-title":"Effect of the phosphatidylinositol 3-kinase\/Akt pathway on influenza A virus propagation","volume":"88","author":"Shin","year":"2007","journal-title":"J. Gen. Virol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nature04304","article-title":"BRAF mutation predicts sensitivity to MEK inhibition","volume":"439","author":"Solit","year":"2006","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib","volume":"366","author":"Sosman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1365-3083.2006.001764.x","article-title":"Role of MAP kinase-dependent apoptotic pathway in innate immune responses and viral infection","volume":"63","author":"Sumbayev","year":"2006","journal-title":"Scand. J. Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e72692","DOI":"10.1371\/journal.pone.0072692","article-title":"Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanoma","volume":"8","author":"Tahiri","year":"2013","journal-title":"PLoS ONE"},{"key":"B68","doi-asserted-by":"publisher","first-page":"43861","DOI":"10.1074\/jbc.M406240200","article-title":"MEK1 and MEK2, different regulators of the G1\/S transition","volume":"279","author":"Ussar","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e00969","DOI":"10.7554\/eLife.00969","article-title":"BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling","volume":"2","author":"Vin","year":"2013","journal-title":"Elife"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1038\/sj.onc.1207556","article-title":"Mitogen-activated protein kinases in apoptosis regulation","volume":"23","author":"Wada","year":"2004","journal-title":"Oncogene"},{"key":"B71","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fcimb.2017.00027","article-title":"HA triggers the switch from MEK1 SUMOylation to Phosphorylation of the ERK Pathway in influenza a virus-infected cells and facilitates its infection","volume":"7","author":"Wang","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B72","volume-title":"WHO Guidelines for Pharmaceutical Management of Pandemic Influenza A (H1N1) 2009 and Other Influenza Viruses","year":"2010"},{"key":"B73","doi-asserted-by":"publisher","first-page":"30931","DOI":"10.1074\/jbc.M403258200","article-title":"NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas\/FasL is crucial for efficient influenza virus propagation","volume":"279","author":"Wurzer","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1093\/emboj\/cdg279","article-title":"Caspase 3 activation is essential for efficient influenza virus propagation","volume":"22","author":"Wurzer","year":"2003","journal-title":"EMBO J."},{"key":"B75","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1158\/0008-5472.CAN-11-2941","article-title":"Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer","volume":"72","author":"Yang","year":"2012","journal-title":"Cancer Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nature14982","article-title":"RAF inhibitors that evade paradoxical MAPK pathway activation","volume":"526","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s10495-007-0071-y","article-title":"Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling","volume":"12","author":"Zhirnov","year":"2007","journal-title":"Apoptosis"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2017.02426\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T04:29:13Z","timestamp":1513225753000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2017.02426\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,14]]},"references-count":77,"alternative-id":["10.3389\/fmicb.2017.02426"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2017.02426","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,14]]},"article-number":"2426"}}